Global Liver Institute

It all starts with a patient

Global Liver Institute saves lives by empowering patient advocates to collaborate with policymakers, clinicians, and industry to drive the liver health field forward.

It all starts with a patient

Global Liver Institute saves lives by empowering patient advocates to collaborate with policymakers, clinicians, and industry to drive the liver health field forward.

It all starts with a patient

Global Liver Institute saves lives by empowering patient advocates to collaborate with policymakers, clinicians, and industry to drive the liver health field forward.

It all starts with a patient

Global Liver Institute saves lives by empowering patient advocates to collaborate with policymakers, clinicians, and industry to drive the liver health field forward.

It all starts with a patient

Global Liver Institute saves lives by empowering patient advocates to collaborate with policymakers, clinicians, and industry to drive the liver health field forward.

It all starts with a patient

Global Liver Institute saves lives by empowering patient advocates to collaborate with policymakers, clinicians, and industry to drive the liver health field forward.

It all starts with a patient

Global Liver Institute saves lives by empowering patient advocates to collaborate with policymakers, clinicians, and industry to drive the liver health field forward.

Patient Testimonials

How we’re making a difference.

Katelin Img

Dr. Katelin H.

“There is nothing more powerful than sharing your story with others, whether with your own family or with the whole country. You’d be surprised how much impact simple actions can have.”

Karen Hoyt

Karen Hoyt

“Connecting to others with liver disease is so crucial. It is easy to get caught in a cycle of malnutrition, fatigue, isolation, depression, pain, and on it goes. By reaching out to others, and their caregivers, I aspire to inspire connections from around the globe.”

Elena

Elena Covarrubias

“As a professional I’ve worked with hundred of people with NASH and detected some others. I know this disease is not known enough by people and by health professionals, even physicians. My duty is to identify those in risk of developing NASH and NAFLD.”

SEE MORE

About GLI

Improving the lives of individuals & families.

Global Liver Institute (GLI) is a nonprofit organization founded in the belief that liver health must take its place on the global public health agenda commensurate with the prevalence and impact of liver illness.

GLI promotes innovation, encourages collaboration, and supports the scaling of optimal approaches to help eradicate liver diseases. Operating globally, GLI is committed to solving the problems that matter to liver patients and equipping advocates to improve the lives of individuals and families impacted by liver disease.

LEARN MORE ABOUT US

Global Liver Home3

1.5 Billion

People around the globe are currently living with liver disease¹

1 In 4

1 in 4

People are estimated to already have NAFLD or NASH²

Woman Showing Liver

Less than 27%

Of people with liver cancer survive five years after diagnosis, worldwide.³

GLI LIVE

GLI LIVE started in March 2020, as a COVID-19 response program for liver patients. It has now evolved into a weekly educational show with tailored information for patients living with liver diseases on a variety of timely topics.

WATCH LATEST EPISODES

GLI APPETITE™

GLI and NutriStyle Inc. have partnered to create a personalized nutrition app for people living with liver disease, diabetes, and other chronic conditions or who want to maintain good liver health. The app will create personalized meal plans to meet the specific requirements set out by GLI nutritional advisors for people with NASH or a general interest in liver health.

Liver Central

Global Liver Institute created Liver Central to equip everyone affected by liver cancer. We know that learning, advocacy, and collaboration empowers us to create change in the exam room, in the community, and beyond. Whether you have just received a liver cancer diagnosis, you are interested in new treatment options or clinical trials, or you’re a clinician looking for current practice guidelines, Liver Central exists to help you find the answers you pursue.

People High Fiving

Over 200 advocates trained through GLI’s Advanced Advocacy Academy (A3)

3 1

Partners and advocates in 5 continents, 36 countries, and 42 U.S. states

200 multidisciplinary stakeholders work together on our councils

Latest Updates

Global Liver Institute Acknowledges FDA Request for Further Studies as Obeticholic Acid Remains Available for PBC Patients

Global Liver Institute (GLI) acknowledges the U.S. Food and Drug Administration’s (FDA) decision today to issue a Complete Response Letter (CRL) for the supplemental New Drug Application (sNDA) of obeticholic acid (OCA, OCALIVA®) for primary biliary cholangitis (PBC).

Liver Health Policy Update

After elections, a lame-duck Congress will need to pass appropriations bills and hopefully “clear the decks” by passing long-awaited health reforms – Liver Health Policy Update

Members of Congress will return to Washington, DC, after the elections. Hopes remain for a productive November legislative session where some legislative priorities may finally make it to final passage.

Liver Cancer News Square

Uniting for Equity in Liver Cancer Care – Liver Cancer News

In October, Global Liver Institute led its annual #OctoberIs4Livers campaign, focused on health equity and raising awareness about liver cancer.

More News